Clinical Scorecard: A predictive nomogram for elderly individuals with unresectable esophageal cancer receiving intensity-modulated radiotherapy
At a Glance
Category
Detail
Condition
Unresectable esophageal squamous cell carcinoma (ESCC) in elderly patients
Key Mechanisms
Integration of clinical features and nutritional-inflammatory biomarkers to predict prognosis and guide personalized IMRT treatment
Target Population
Elderly patients (≥65 years) with pathologically confirmed ESCC who are ineligible for surgery
Care Setting
Oncology and radiotherapy departments providing intensity-modulated radiotherapy (IMRT) with or without chemotherapy
Key Highlights
Esophageal cancer is highly prevalent and lethal in China, with many elderly patients presenting with advanced disease unsuitable for surgery.
IMRT combined with chemotherapy is preferred for unresectable EC due to better efficacy and lower toxicity compared to other radiotherapy methods.
A novel nomogram incorporating clinical and nutritional-inflammatory indices aims to improve personalized treatment decisions and prognosis prediction in elderly EC patients.
Guideline-Based Recommendations
Diagnosis
Pathological confirmation of esophageal squamous cell carcinoma.
Clinical staging according to AJCC/UICC 8th edition.
Assessment of nutritional and inflammatory biomarkers prior to IMRT.
Management
Use intensity-modulated radiotherapy (IMRT) as the preferred radiotherapy technique.
Recommend concurrent chemotherapy with fluorouracil or capecitabine combined with platinum when tolerated.
Provide nutritional support during treatment, including nasal feeding or gastrostomy as needed.
Employ involved-field irradiation without routine prophylactic lymph node irradiation.
Monitoring & Follow-up
Regular evaluation of treatment tolerance considering elderly patients’ frailty and comorbidities.
Monitor for complications such as esophageal ulcers, perforation, bleeding, and infection.
Assess nutritional status continuously to address malnutrition risks.
Risks
High risk of malnutrition (62.8%) impacting treatment tolerance and outcomes.
Potential complications from radiotherapy and chemotherapy including organ toxicity and infections.
Challenges in treatment compliance due to age-related physiological decline and comorbidities.
Patient & Prescribing Data
Elderly patients aged 65 years and older with unresectable ESCC undergoing IMRT without surgery.
Concurrent chemotherapy regimens include PF (cisplatin and fluorouracil) or single-agent S-1, with dosing adjusted by body surface area; nutritional support is integral to treatment.
Clinical Best Practices
Select elderly EC patients carefully for IMRT based on performance status and comorbidities.
Incorporate comprehensive nutritional and inflammatory biomarker assessment to guide prognosis and personalize treatment.
Use involved-field irradiation to minimize exposure to normal tissues and reduce toxicity.
Provide proactive nutritional interventions to mitigate malnutrition and improve treatment tolerance.
Apply nomogram tools integrating clinical and biomarker data to support individualized dose adjustments and care planning.
The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.
